Head-to-Head Comparison of 68 Ga-PSMA-11 with 68 Ga-P137 in Patients with Suspected Prostate Cancer
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.3c00522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Tingting Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.
ORCID-Profile: Tingting Han, Mingru Zhang, Jiajun Ye
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Han, T., Quan, Z., Wang, M., Meng, X., Zhang, M., Ye, J., Li, G., Wang, J., & Kang, F. (2023). Head-to-Head Comparison of 68 Ga-PSMA-11 with 68 Ga-P137 in Patients with Suspected Prostate Cancer. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00522
Vancouver
Han T, Quan Z, Wang M, Meng X, Zhang M, Ye J, et al. Head-to-Head Comparison of 68 Ga-PSMA-11 with 68 Ga-P137 in Patients with Suspected Prostate Cancer. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00522
BibTeX
@article{Han2023,
author = {Han, Tingting and Quan, Zhiyong and Wang, Min and Meng, Xiaoli and Zhang, Mingru and Ye, Jiajun and Li, Guiyu and Wang, Jing and Kang, Fei},
title = {Head-to-Head Comparison of 68 Ga-PSMA-11 with 68 Ga-P137 in Patients with Suspected Prostate Cancer},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.3c00522}
}
EUVIMED